Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes

Differentiation

Volumn 79, Issue 2, 2010, Pages 93-101

  Labovsky, V ^a,b,c   Hofer, E L ^b,c   Feldman, L ^d   Fernandez Vallone V ^b,c   Garcia Rivello H ^a   Bayes Genis, A ^e   Hernando Insua A ^f   Levin, M J ^a,b   Chasseing, N A ^b,c  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b Ciencia y Técnica ^*  (Argentina)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f Immunotech SA   (Argentina)

Author keywords

Cardiomyogenic differentiation; Cell extract and Streptolysin O; Human mesenchymal stromal cells

Indexed keywords

ALPHA ACTININ; AZACITIDINE; BETA 1 ADRENERGIC RECEPTOR; CONNEXIN 43; DESMIN; HEART MUSCLE EXTRACT; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STREPTOLYSIN O; TRANSCRIPTION FACTOR GATA 4; TROPONIN I; TROPONIN T;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHOOL CHILD;

ADOLESCENT; ADULT; ANIMALS; AZACITIDINE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CHILD; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELLS; MYOCYTES, CARDIAC; RATS;

RATTUS;

EID: 77249153994     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2009.10.001     Document Type: Article

References (35)

1. Abraham M.R., Henrikson C.A., Tung L., Chang M.G., Aon M., Xue T., Li R.A., O' Rourke B., and Marbán E. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. 97 (2005) 159-167
2. Antonitsis P., Ioannidou-Papagiannaki E., Kaidoglou A., Charokopos N., Kalogeridis A., Kouzi-Koliakou K., Kyriakopoulou I., Klonizakis I., and Papakonstantinou C. Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro. Thorac. Cardiovasc. Surg. 56 (2008) 77-82
3. Aoyagi T., Yonekura K., Eto Y., Matsumoto A., Yokoyama I., Sugiura S., Momomura S., Hirata Y., Baker D.L., and Periasamy M. The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressure-overload hypertrophy in rat hearts. J. Mol. Cell. Cardiol. 31 (1999) 919-926
4. Bayes-Genis A., Roura S., Soler-Botija C., Farré J., Hove-Madsen L., Llach A., and Cinca J. Identification of cardiomyogenic lineage markers in untreated human bone marrow-derived mesenchymal stem cells. Transplant. Proc. 37 (2005) 4077-4079
5. Beltrami A.P., Cesselli D., Bergamin N., Marcon P., Rigo S., Puppato E., D'Aurizio F., Verardo R., Piazza S., Pignatelli A., Poz A., Baccarani U., Damiani D., Fanin R., Mariuzzi L., Finato N., Masolini P., Burelli S., Belluzzi O., Schneider C., and Beltrami C.A. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 110 (2007) 3438-3446
6. Breitbach M., Bostani T., Roell W., Xia Y., Dewald O., Nygren J.M., Fries J.W., Tiemann K., Bohlen H., Hescheler J., Welz A., Bloch W., Jacobsen S.E., and Fleischmann B.K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110 (2007) 1362-1369
7. Brewer A.C., Alexandrovich A., Mjaatvedt C.H., Shah A.M., Patient R.K., and Pizzey J.A. GATA factors Lie Upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects cardiogenesis. Stem Cells Dev. 14 (2005) 425-439
8. Charwat S., Gyöngyösi M., Lang I., Graf S., Beran G., Hemetsberger R., Nyolczas N., Sochor H., and Glogar D. Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp. Hematol. 36 (2008) 672-680
9. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., and Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
10. Fine G.C., Liao R., and Sohn R.L. Cell therapy for cardiac repair. Panminerva Med 50 (2008) 129-137
11. Fukuda K., and Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ. Res. 98 (2006) 1002-1013
12. Gaustad K.G., Boquest A.C., Anderson B.E., Gerdes A.M., and Collas P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem. Biophys. Res. Commun. 314 (2004) 420-427
13. Gillum N., and Sarvazyan N. Adhesion proteins, stem cells, and arrhythmogenesis. Cardiovasc. Toxicol. 8 (2008) 10-13
14. Guttenbach M., and Schmid M. Exclusion of specific human chromosomes into micronuclei by 5-azacytidine treatment of lymphocyte cultures. Exp. Cell Res. 211 (1994) 127-132
15. Håkelien A.M., Gaustad K.G., and Collas P. Transient alteration of cell fate using a nuclear and cytoplasmic extract of an insulinoma cell line. Biochem. Biophys. Res. Commun. 316 (2004) 834-841
16. Hakuno D., Fukuda K., Makino S., Konishi F., Tomita Y., Manabe T., Suzuki Y., Umezawa A., and Ogawa S. Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation 105 (2002) 380-386
17. Haniffa M.A., Wang X.N., Holtick U., Rae M., Isaacs J.D., Dickinson A.M., Hilkens C.M., and Collin M.P. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J. Immunol. 179 (2007) 1595-1604
18. He Q., Wan C., and Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25 (2007) 69-77
19. Iso Y., Spees J.L., Serrano C., Bakondi B., Pochampally R., Song Y.H., Sobel B.E., Delafontaine P., and Prockop D.J. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem. Biophys. Res. Commun. 354 (2007) 700-706
20. Kadivar M., Khatami S., Mortazavi Y., Shokrgozar M.A., Taghikhani M., and Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 340 (2006) 639-647
21. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., and Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31 (2003) 890-896
22. Li X., Yu X., Lin Q., Deng C., Shan Z., Yang M., and Lin S. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J. Mol. Cell. Cardiol. 42 (2007) 295-303
23. Mahler E., Hoebeke J., and Levin M.J. Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease. Clin. Exp. Immunol. 136 (2004) 527-534
24. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., and Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103 (1999) 697-705
25. Menasché P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., Vilquin J.T., Marolleau J.P., Seymour B., Larghero J., Lake S., Chatellier G., Solomon S., Desnos M., and Hagège A.A. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
26. Minguell J.J., and Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp. Biol. Med. 231 (2006) 39-49
27. Nassiri S.M., Khaki Z., Soleimani M., Ahmadi S.H., Jahanzad I., Rabbani S., Sahebjam M., Ardalan F.A., and Fathollahi M.S. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J. Biomed. Sci. 14 (2007) 745-755
28. Nauta A.J., and Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007) 3499-3506
29. Phinney D.G., and Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25 (2007) 2896-2902
30. Prockop D.J. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin. Pharmacol. Ther. 82 (2007) 241-243
31. Shiojima I., Komuro I., Oka T., Hiroi Y., Mizuno T., Takimoto E., Monzen K., Aikawa R., Akazawa H., Yamazaki T., Kudoh S., and Yazaki Y. Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. J. Biol. Chem. 274 (1999) 8231-8239
32. Silva G.V., Litovsky S., Assad J.A., Sousa A.L., Martin B.J., Vela D., Coulter S.C., Lin J., Ober J., Vaughn W.K., Branco R.V., Oliveira E.M., He R., Geng Y.J., Willerson J.T., and Perin E.C. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
33. Stopper H., Korber C., Gibis P., Spencer D.L., and Caspary W.J. Micronuclei induced by modulators of methylation: analogs of 5-azacytidine. Carcinogenesis 16 (1995) 1647-1650
34. Stresemann C., Brueckner B., Musch T., Stopper H., and Lyko F. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 66 (2006) 2794-2800
35. Tomita S., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Sakai T., and Jia Z.Q. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100 (1999) II247-256